Bladder Carcinoma
📧 Sign up to get email alerts when something new happens for Bladder Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-11-24Clinical Trial Update: First-line Everolimus +/- Paclitaxel for Cisplatin-ineligible Patients With Advanced Urothelial Carcinoma [Phase 2]
Phase 2 trial evaluating first-line everolimus with or without paclitaxel in cisplatin-ineligible advanced urothelial carcinoma was terminat…
-
CLINICAL_TRIALS trial_result · 2021-02-25Clinical Trial Update: TracelT Hydrogel in Localizing Bladder Tumors in Patients Undergoing Radiation Therapy for Bladder Cancer [NA]
A completed clinical trial evaluating TracelT Hydrogel for localizing bladder tumors in patients undergoing radiation therapy for bladder ca…
-
CLINICAL_TRIALS trial_result · 2021-02-25Clinical Trial Update: hARnessing CAbozantinib and Durvalumab Immuno-oncology Association: ARCADIA Study" [Phase 2]
Phase 2 trial update investigating cabozantinib and durvalumab in bladder carcinoma (ARCADIA study) with status currently UNKNOWN.
-
CLINICAL_TRIALS trial_result · 2019-06-04Clinical Trial Update: Gabapentin in Reducing the Need for Pain Medication in Patients With Bladder Cancer Undergoing Radical Cystectomy [Phase 2, Phase 3]
Phase 2/3 clinical trial evaluating gabapentin to reduce postoperative pain medication use in bladder cancer patients undergoing radical cys…
-
CLINICAL_TRIALS trial_result · 2016-03-24Clinical Trial Update: Phase II Study of Isoflavone G-2535 (Genistein) in Patients With Bladder Cancer [Phase 2]
A Phase II study of Genistein (Isoflavone G-2535) in bladder cancer has completed and results were posted in 2016.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.